NASDAQ:WINT

Windtree Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy WINT

*Your capital is at risk

$0.0140

+0.0004 (+2.94%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

WINT Prediction Chart

WINT Predictions History

Latest community submissions for WINT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
teodoropolstefan.240397	Jun 7, 2021	Bullish	$2.79	X	—	1
bbullish2 Merchant @bbullish2.7792	Jul 3, 2017	$0.328 -100.00%	$0.320	X	96.50%	0
JS Pro	Jul 3, 2017	$0.414 -100.00%	$0.320	X	69.40%	0
JS Pro	May 11, 2017	$0.730 -100.00%	$0.700	X	95.70%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for WINT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT WINDTREE THERAPEUTICS INC

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by